The Medicare population is projected to increase from 54 million+ beneficiaries today to over 80 million beneficiaries by 2030 as the baby-boomer generation ages into Medicare. This expansion will bring changes to the Medicare population. First, the average age of the Medicare population will initially skew younger than in the recent past, but then grow rapidly older as the number and share of beneficiaries ages 85 and older increases.
This week, Durig Capital looks to a Canadian issuer, a specialty pharmaceutical company that is successfully treating long-term HIV patients with its unique medicines so that patients have the opportunity to have a better quality of life. Theratechnologies (TSX:TH) has two landmark drugs, Trogarzo™ and EGRIFTA™ specifically developed to help HIV patients. The company has reported its second quarter results (for the three months ending May 31, 2019) and continues to see outstanding growth over its product lines.